OrthoPediatrics acquires U.S. distribution rights for innovative pediatric bracing solutions through Thrive Orthopedics partnership.
Quiver AI Summary
OrthoPediatrics Corp. has announced that its Specialty Bracing (OPSB) division has secured distribution rights to bring several new pediatric bracing solutions to the U.S. market through a partnership with Thrive Orthopedics LLC. The agreement introduces three innovative orthotic products: the lightweight F3 Hero Pediatric AFO, which aids stability and walking flexibility for children with mobility challenges; the TruStretch Pediatric Equinus Brace®, designed for optimal muscle stretching in children with equinus deformity; and the Thrive® Pediatric X-Glide Carbon Fiber Insoles, available in both rigid and flexible styles for gait training. Joe Hauser, President of OPSB, expressed pride in advancing non-operative care solutions to help more children, marking a significant step in OrthoPediatrics' growth strategy.
Potential Positives
- OrthoPediatrics has gained distribution rights to additional pediatric bracing solutions, expanding their product offerings and market presence in the pediatric orthopedic sector.
- The partnership with Thrive Orthopedics LLC enables OrthoPediatrics to introduce innovative and specialized products like the F3 Hero Pediatric AFO and TruStretch Pediatric Equinus Brace®, enhancing their portfolio of non-operative care solutions for children.
- This distribution agreement represents a significant step in OrthoPediatrics' planned growth strategy, aiming to increase their reach and impact in helping children with orthopedic conditions worldwide.
Potential Negatives
- Lack of detailed financial implications of the new distribution agreement, which could raise concerns about profitability and investment returns.
- No mention of potential competition or market risks associated with expanding into new product lines, which could affect future growth.
- Absence of specific targets or timelines for the growth mentioned by management, leaving investors uncertain about expected outcomes.
FAQ
What recent announcement did OrthoPediatrics make?
OrthoPediatrics announced it gained distribution rights to new pediatric bracing solutions through its OPSB division.
What are the specific products included in the distribution agreement?
The agreement includes the Thrive Orthopedics F3 Hero Pediatric AFO, TruStretch Pediatric Equinus Brace®, and Pediatric X-Glide Carbon Fiber Insoles.
Who benefits from the Thrive Orthopedics AFO products?
The Thrive Orthopedics AFOs are designed for children with walking challenges due to conditions like cerebral palsy and spina bifida.
What is the mission of OrthoPediatrics Corp.?
OrthoPediatrics is dedicated to advancing pediatric orthopedics by providing innovative, non-operative care solutions for children worldwide.
How can I learn more about OrthoPediatrics' products?
For more information, visit OrthoPediatrics' website at www.orthopediatrics.com or the OPSB portfolio at https://opsb.com/.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$KIDS Insider Trading Activity
$KIDS insiders have traded $KIDS stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $KIDS stock by insiders over the last 6 months:
- DANIEL J GERRITZEN (General Counsel and Secretary) sold 10,000 shares for an estimated $293,000
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$KIDS Hedge Fund Activity
We have seen 57 institutional investors add shares of $KIDS stock to their portfolio, and 47 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BROWN CAPITAL MANAGEMENT LLC removed 351,848 shares (-13.6%) from their portfolio in Q3 2024, for an estimated $9,538,599
- MORGAN STANLEY added 305,837 shares (+93.1%) to their portfolio in Q3 2024, for an estimated $8,291,241
- PROSIGHT MANAGEMENT, LP removed 200,216 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $5,427,855
- DEUTSCHE BANK AG\ removed 165,323 shares (-94.8%) from their portfolio in Q3 2024, for an estimated $4,481,906
- WELLINGTON MANAGEMENT GROUP LLP added 122,846 shares (+16.2%) to their portfolio in Q3 2024, for an estimated $3,330,355
- PORTOLAN CAPITAL MANAGEMENT, LLC added 122,770 shares (+66.2%) to their portfolio in Q3 2024, for an estimated $3,328,294
- SG CAPITAL MANAGEMENT LLC removed 122,621 shares (-77.0%) from their portfolio in Q3 2024, for an estimated $3,324,255
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
WARSAW, Ind., Jan. 22, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company gained distribution rights to bring additional bracing solutions to the US market through its OrthoPediatrics Specialty Bracing (OPSB) division.
OrthoPediatrics’ OPSB division has established a distribution agreement with Thrive Orthopedics LLC focused on three unique pediatric orthotic solutions. The Thrive Orthopedics F3 Hero Pediatric AFO is a lightweight carbon fiber ankle foot orthosis that provides the stability needed to improve walking while allowing flexibility and energy return at the correct moments to produce a more normalized, smooth, and dynamic walking pattern. This type of AFO is indicated for children who have challenges walking due to cerebral palsy, spina bifida, foot drop due to chemotherapy, or many other diagnoses. The TruStretch Pediatric Equinus Brace
®
is an innovative “above the knee” bracing solution that provides optimal stretching of the gastroc-soleus muscles for children with equinus deformity. The Thrive
®
Pediatric X-Glide Carbon Fiber Insoles come in both rigid and flexible foot plate styles and offer low profile and lightweight gait training tools.
Joe Hauser, OrthoPediatrics Specialty Bracing division President, commented, “The OPSB team is starting the new year off with exciting news. I am so proud of everything we are advancing to help more KIDS with non-operative care. The distribution agreement with Thrive Orthopedics represents the next phase of our planned growth, bringing more innovative solutions to children around the world.”
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 70 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit www.orthopediatrics.com. For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit
https://opsb.com/
.
About Thrive Orthopedics
Thrive Orthopedics was founded on one simple premise; to help practitioners and patients by designing and delivering the best carbon fiber AFOs in the world. We believe our products have the best function, craftsmanship, value, and warranty in the entire industry. We are delivering health with compassion and care.
Investor Contact
Philip Trip Taylor
Gilmartin Group
philip@gilmartinir.com
415-937-5406
This article was originally published on Quiver News, read the full story.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
